Ninjin-Youei-To study

JRCT ID: jRCT1051190012

Registered date:28/04/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: anemia
• Date of first enrollment: 13/12/2017
• Target sample size: 50
• Study type: Interventional

Intervention(s)

Arm Ninjin-Youei-To: oral Ninjin-Youei-To 7.5mg per a day and oral Ferromia 50mg twice a day for 10 days or more until the admission date.
Arm Ferromia: oral Ferromia 50mg twice a day for 10 days or more until the admission date.

Outcome(s)

• Primary Outcome: Hb, fatigue and anxiety
• Secondary Outcome: RBC, Platelet, Ht, Ferritin, Fe, TIBC, UIBC and insomnia

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Female

Include criteria

Patients who receive gynecologic operation and take Ferromia by diagnosing as anemia (Hb less than 11g/dl)
They subject with age more than 20 years

Exclude criteria

1. Patients with concomitant use of other Japanese herbal medicine
2. Patients with use of Japanese herbal medicine for fatigue, insomnia and anxiety within two weeks
3. Patients with depression
4. Patients with aldosteronism, myopathy and hypokalemia
5. Patients with liver dysfunction(AST more than 80 IU/L or ALT more than 80 IU/L)
6. Patients who are inappropriate to participate in the study

Related Information

• Primary Sponsor: Kimura Tadashi
• Secondary ID(s): UMIN000029525